Smiling father with son riding piggyback on a hike

Expert Acute Lymphoblastic Leukemia Care in Your Area

Providence cancer care specialists are highly skilled and have a deep understanding of acute lymphoblastic leukemia treatments. Using our patient-centric and multidisciplinary approach to treatment and patient care, we offer you the most effective treatment options available. Our leading-edge cancer treatment centers are also known for providing high-quality care at an affordable cost.

Acute lymphoblastic leukemia affects everyone differently. This is why we are dedicated to developing an individual treatment plan and supporting you every step of the way.

Find a Location

Why Choose Us for Leukemia Care?

At Providence, we see the life in you. Together, let’s finish cancer – so you don’t have to miss any of life’s special moments.

Doctor smiling at patient

No two patients, or their treatment plans, are alike. This is why, at Providence, we take a highly personalized approach to your leukemia care. You’ll experience this through our multidisciplinary tumor boards, where your oncology team collaborates with other cancer care experts about your specific diagnosis. We also offer a Providence Molecular Tumor Board, where we evaluate your genomic and clinical information to find the best genetically matched treatment for you. Additionally, your oncology team will work with you directly to design a treatment plan that fits your personal needs. It’s an approach that combines leading-edge treatment with the compassionate care Providence is known for. Why? Because we know this results in the best outcomes.

As a patient, you’ll be supported through your entire cancer journey by a multidisciplinary cancer care team. You’ll be treated by board-certified medical oncologists, hematologists and radiation oncologists. It’s a team-based approach to treating leukemia care. Your care team may also include oncology nurse navigators, genetic risk experts, pulmonologists, fertility preservationists and other cancer specialists. We also provide you and your family with a full range of support services well beyond conventional treatment, from genetic counseling and education to nutrition and pain management.

Learn more about the experts who make up our multidisciplinary cancer care teams.

Cancer doesn’t discriminate, but access to great leukemia care hasn’t always been the same for everyone. At Providence, we are deeply committed to making sure every patient we treat has access to the best cancer care. We offer various location-specific services to help our patients receive equitable care, such as translation for non-English-speaking patients, telehealth and transportation assistance. We value, respect and support the racial, ethnic, religious, spiritual, gender, and sexual identities of each member of our diverse communities, and we welcome all patients, regardless of their ability to pay. We aim to make sure every patient is treated equally and with dignity – whoever you are, and wherever you’re at.

As a patient at Providence, you have access to the largest community-based cancer network in the United States. Being part of a collaborative network means that your local leukemia care team shares knowledge and experience with other world-class clinicians across 51 hospitals in seven states. The extent and power of our network is one of the reasons more than 1,000 new leukemia patients, and 50,000 new cancer patients, choose Providence each year.

Providence is well known for offering options – and hope – to patients seeking the most advanced procedures and therapies to treat leukemia. We participate in the Bone Marrow Transplant Clinical Trials Network and the National Clinical Trials Network. As a patient, you have the opportunity to participate in one of over 70 clinical trials happening across the Providence network for leukemia treatment, including studies on the effectiveness of different chemotherapy drug combinations.

Our Approach

At Providence, we recognize the everyday challenge an acute lymphoblastic leukemia diagnosis brings, and the toll it can take on our patients. We offer personalized, research-based acute lymphoblastic leukemia treatment plans tailored to meet your needs. We will be there to hold your hand through the process and beyond.

Our doctors are among the country's most highly skilled cancer care specialists, so you're in good hands at Providence. They have deep expertise, advanced skills, compassion, and dedication to ensuring you're provided with the most effective acute lymphoblastic leukemia treatments available.

Providence cancer care specialists treat acute lymphoblastic leukemia by using chemotherapy, targeted therapy, radiation therapy, immunotherapy, and other treatments. There are also options to participate in clinical trials for alternative therapies available.

Acute Lymphoblastic Leukemia Care Locations

Meet the Team

At Providence, you'll have access to a vast network of dedicated and compassionate providers who offer personalized care by focusing on treatment, prevention and health education.

Female doctor wearing mask, doctors in background

Find Care

Expert Tips and Advice for Cancer

Comprehensive Genomic Profiling leads to better patient outcomes, new joint study says  
Real-world data from Providence, Illumina and Microsoft Research finds cancer patients with early genomic testing received better precision treatment, underlines urgency to become standard practice
Leadership change at Providence Cancer Institute, #FINISHCANCER goal remains
11/14/2024
R. Bryan Bell, M.D., D.D.S., FACS, FRCS(Ed) has accepted the roles of executive medical director of Providence Cancer Institute and director of the Earle A. Chiles Research Institute.
2024 SITC Meeting: A glimpse of recent advancements in immunotherapy
11/11/2024
The annual SITC meeting brings together cancer immunotherapy researchers with a goal to advance science, discover breakthroughs and educate the world on cancer immunotherapy.
Harnessing CAR T-cell therapy: A new study for indolent B-cell non-Hodgkin lymphoma
10/30/2024
New study evaluates a type of CAR T-cell therapy called liso-cel. Researchers will collect data from multiple groups in a study that may give patients hope for long-term remission and quality of life.
Read More Articles